Pricing Log in Create free account

Sagimet Biosciences Inc. (SGMT) vs Solid Biosciences Inc. (SLDB)

Sagimet Biosciences Inc. and Solid Biosciences Inc. are both Biotechnology companies. Sagimet Biosciences Inc. and Solid Biosciences Inc. are of similar size ($662.7M and $641.5M). Across the 9 metrics below, Sagimet Biosciences Inc. leads on 6 and Solid Biosciences Inc. on 3.

Valuation

Metric SGMT SLDB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 88.22 9.40
P/B 2.04 2.90 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 57.17 9.02
Earnings yield (13.03%) (27.20%) (32.88%)
Free cash flow yield (8.00%) (20.18%) (23.13%)

Profitability

Metric SGMT SLDB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (24.37%) (76.87%) (51.96%)
Return on assets (23.49%) (64.86%) (46.06%)
Return on invested capital (205.24%) 0.00% 0.00%

Growth

Metric SGMT SLDB Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (8.97%) 34.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SGMT SLDB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.02 11.99 4.97
Net debt to EBITDA 1.98 1.05 1.01

Dividend

Metric SGMT SLDB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SGMT SLDB Biotechnology median
Market cap 641.51m 662.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack